Concepedia

Michael A. Moskal

MA

Statistics

Publications

6

Citations

190

H-Index

6

Active since

1991

Affiliations

Novartis (Switzerland)(Current)

Tris Pharma (United States)

Michael A. Moskal is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1991–2001

6

Publications

6

Design and Synthesis of Potent, Selective Inhibitors of Endothelin-Converting Enzyme

Eli M. Wallace, John Moliterni, Michael A. Moskal et al. · Journal of Medicinal Chemistry · 1998 · 52 citations · Full text

Highly selective adenosine A2 receptor agonists in a series of N-alkylated 2-aminoadenosines

John E. Francis, Randy L. Webb, Geetha Ghai et al. · Journal of Medicinal Chemistry · 1991 · 44 citations · Full text

Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11

Stéphane De Lombaert, Lisa B. Stamford, Louis Blanchard et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 37 citations

, , +8

Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors

Gary M. Ksander, Reynalda deJesus, Andrew Yuan et al. · Journal of Medicinal Chemistry · 2001 · 32 citations · Full text

, , +12

Synthesis of tetrazole analogs of α-amino acids by alkylation of a Schiff base of α-aminomethyltetrazole

Yoshitaka Satoh, Stéphane De Lombaert, Nicholas Marcopulos et al. · Tetrahedron Letters · 1998 · 13 citations

, , +7

Rows per page

1–5 of 6